Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: Systematic review and meta-analysis.
Journal of Crohn's & colitis(2023)
Abstract
JAKi and S1P receptor modulator therapies are effective in IBD for inducing clinical and endoscopic remission and, in some circumstances, histologic response.
MoreTranslated text
Key words
JAK inhibitors, S1P receptor modulators, inflammatory bowel disease
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined